By controlling the ingredients, you can ensure it contains no preservatives or additives such as carboxymethyl cellulose (cellulose gum) and mannitol as many pre-packaged B12 injection kits did
Neurological symptoms such as paraesthesia, ataxia, and cognitive impairment can occur before haematological changes and may become irreversible if treatment is delayed
Once reconstituted, researchers commonly store the solution refrigerated (2-8C) and reference internal stability testing or published peptide-handling guidance to determine an appropriate usage window
Most research involves animal studies, and the Phase 1 human trial completed in 2015 never published results
The regulatory and legal status of BPC-157 is that of an unapproved research compound in the United States and in most global jurisdictions, with no marketing authorization from any major regulatory agency for human therapeutic use
doi: 10.1182/blood-2007-03-082586 A